{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:25:12Z","timestamp":1787019912033,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R310-2018-3711"],"award-info":[{"award-number":["R310-2018-3711"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R310-2018-3711"],"award-info":[{"award-number":["R310-2018-3711"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R310-2018-3711"],"award-info":[{"award-number":["R310-2018-3711"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R310-2018-3711"],"award-info":[{"award-number":["R310-2018-3711"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R403-2022-1352"],"award-info":[{"award-number":["R403-2022-1352"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02037-9","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T06:02:18Z","timestamp":1745474538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma SuPAR and therapeutic response to erenumab in migraine: a REFORM study"],"prefix":"10.1186","volume":"26","author":[{"given":"William K.","family":"Karlsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune H.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidar M.","family":"Al-Khazali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kallemose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baker N.","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ove","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"2037_CR1","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383:1866\u20131876. https:\/\/doi.org\/10.1056\/NEJMra1915327","journal-title":"N Engl J Med"},{"key":"2037_CR2","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s13311-022-01230-x","volume":"19","author":"F Cohen","year":"2022","unstructured":"Cohen F, Yuan H, DePoy EMG, Silberstein SD (2022) The arrival of Anti-CGRP monoclonal antibodies in migraine. Neurotherapeutics 19:922\u2013930. https:\/\/doi.org\/10.1007\/s13311-022-01230-x","journal-title":"Neurotherapeutics"},{"key":"2037_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s10194-022-01433-9","volume":"23","author":"CK Cullum","year":"2022","unstructured":"Cullum CK, Do TP, Ashina M et al (2022) Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study. J Headache Pain 23:61. https:\/\/doi.org\/10.1186\/s10194-022-01433-9","journal-title":"J Headache Pain"},{"key":"2037_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/ph16070934","volume":"16","author":"JB Hong","year":"2023","unstructured":"Hong JB, Lange KS, Overeem LH et al (2023) A scoping review and Meta-Analysis of Anti-CGRP monoclonal antibodies: predicting response. Pharmaceuticals 16:934. https:\/\/doi.org\/10.3390\/ph16070934","journal-title":"Pharmaceuticals"},{"key":"2037_CR5","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al-Karagholi MAM et al (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet (London England) 397:1496\u20131504. https:\/\/doi.org\/10.1016\/S0140-6736(20)32162-0","journal-title":"Lancet (London England)"},{"key":"2037_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/gerona\/glaa178","volume":"76","author":"LJH Rasmussen","year":"2021","unstructured":"Rasmussen LJH, Caspi A, Ambler A et al (2021) Association between elevated SuPAR, a new biomarker of inflammation, and accelerated aging. Journals Gerontol - Ser Biol Sci Med Sci 76:318\u2013327. https:\/\/doi.org\/10.1093\/gerona\/glaa178","journal-title":"Journals Gerontol - Ser Biol Sci Med Sci"},{"key":"2037_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ijcard.2012.03.040","volume":"167","author":"S Lyngb\u00e6k","year":"2013","unstructured":"Lyngb\u00e6k S, Sehestedt T, Marott JL et al (2013) CRP and SuPAR are differently related to anthropometry and subclinical organ damage. Int J Cardiol 167:781\u2013785. https:\/\/doi.org\/10.1016\/j.ijcard.2012.03.040","journal-title":"Int J Cardiol"},{"key":"2037_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0165-5728(02)00186-8","volume":"129","author":"JC Garcia-Monco","year":"2002","unstructured":"Garcia-Monco JC, Coleman JL, Benach JL (2002) Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases. J Neuroimmunol 129:216\u2013223. https:\/\/doi.org\/10.1016\/S0165-5728(02)00186-8","journal-title":"J Neuroimmunol"},{"key":"2037_CR9","doi-asserted-by":"publisher","unstructured":"Sajanti A, Hellstr\u00f6m S, Bennett C et al (2024) Soluble Urokinase-Type plasminogen activator receptor and inflammatory biomarker response with prognostic significance after acute neuronal Injury\u2013 a prospective cohort study. https:\/\/doi.org\/10.1007\/s10753-024-02185-1. Inflammation","DOI":"10.1007\/s10753-024-02185-1"},{"key":"2037_CR10","doi-asserted-by":"publisher","first-page":"fcae475","DOI":"10.1093\/braincomms\/fcae475","volume":"7","author":"B Tesfay","year":"2024","unstructured":"Tesfay B, Ashina H, Christensen RH et al (2024) Association of plasma soluble urokinase plasminogen activator receptor concentrations and migraine with aura: a REFORM study. Brain Commun 7:fcae475. https:\/\/doi.org\/10.1093\/braincomms\/fcae475","journal-title":"Brain Commun"},{"key":"2037_CR11","doi-asserted-by":"publisher","unstructured":"Y\u0131lmaz N, Y\u0131lmaz M, Sirin B et al (2017) The relationship between levels of plasma-soluble urokinase plasminogen activator receptor (suPAR) and presence of migraine attack and aura. 37:447\u2013452. https:\/\/doi.org\/10.1080\/10799893.2017.1328440. http:\/\/dx.doi.org\/101080\/1079989320171328440","DOI":"10.1080\/10799893.2017.1328440"},{"key":"2037_CR12","doi-asserted-by":"publisher","first-page":"E2038","DOI":"10.1212\/WNL.0000000000007371","volume":"92","author":"DS Albrecht","year":"2019","unstructured":"Albrecht DS, Mainero C, Ichijo E et al (2019) Imaging of neuroinflammation in migraine with aura: A [11\u00a0C]PBR28 PET\/MRI study. Neurology 92:E2038\u2013E2050. https:\/\/doi.org\/10.1212\/WNL.0000000000007371","journal-title":"Neurology"},{"key":"2037_CR13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/ana.25731","volume":"87","author":"N Hadjikhani","year":"2020","unstructured":"Hadjikhani N, Albrecht DS, Mainero C et al (2020) Extra-Axial inflammatory signal in parameninges in migraine with visual aura. Ann Neurol 87:939\u2013949. https:\/\/doi.org\/10.1002\/ana.25731","journal-title":"Ann Neurol"},{"key":"2037_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ana.27197","volume":"00","author":"RH Christensen","year":"2025","unstructured":"Christensen RH, Ashina H, Al-Khazali HM et al (2025) Signs of cortical inflammation in migraine measured with quantitative magnetic resonance imaging: A registry for migraine (REFORM) study. Ann Neurol 00:1\u201312. https:\/\/doi.org\/10.1002\/ana.27197","journal-title":"Ann Neurol"},{"key":"2037_CR15","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","volume":"103","author":"AF Russo","year":"2023","unstructured":"Russo AF, Hay DL (2023) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103:1565\u20131644. https:\/\/doi.org\/10.1152\/physrev.00059.2021","journal-title":"Physiol Rev"},{"key":"2037_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s10194-023-01656-4","volume":"24","author":"HM Al-Khazali","year":"2023","unstructured":"Al-Khazali HM, Ashina H, Wiggers A et al (2023) Calcitonin gene-related peptide causes migraine aura. J Headache Pain 24:124. https:\/\/doi.org\/10.1186\/s10194-023-01656-4","journal-title":"J Headache Pain"},{"key":"2037_CR17","doi-asserted-by":"publisher","first-page":"e17360","DOI":"10.1371\/journal.pone.0017360","volume":"6","author":"L Neeb","year":"2011","unstructured":"Neeb L, Hellen P, Boehnke C et al (2011) IL-1\u03b2 stimulates COX-2 dependent PGE2 synthesis and CGRP release in rat trigeminal ganglia cells. PLoS ONE 6:e17360. https:\/\/doi.org\/10.1371\/journal.pone.0017360","journal-title":"PLoS ONE"},{"key":"2037_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1471-4159.2005.03524.x","volume":"96","author":"EJ Bowen","year":"2006","unstructured":"Bowen EJ, Schmidt TW, Firm CS et al (2006) Tumor necrosis factor-\u03b1 stimulation of calcitonin gene\u2010related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem 96:65\u201377. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03524.x","journal-title":"J Neurochem"},{"key":"2037_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s10194-023-01604-2","volume":"24","author":"WK Karlsson","year":"2023","unstructured":"Karlsson WK, Ashina H, Cullum CK et al (2023) The registry for migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics. J Headache Pain 24:70. https:\/\/doi.org\/10.1186\/s10194-023-01604-2","journal-title":"J Headache Pain"},{"key":"2037_CR20","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"2037_CR21","unstructured":"ViroGates AS (2008) suPARnostic\u00ae AUTO Flex ELISA - Instructions for use (PI 008 v9 UK May 2024). https:\/\/virogates.sharepoint.com\/sites\/Website\/Delte%20dokumenter\/Forms\/AllItems.aspx?id=%2Fsites%2FWebsite%2FDelte%20dokumenter%2FTechnical%20Documents%2FElisa%2FPI%20008%20v9%20UK%20May%202024%20AUTO%20Flex%20ELISA%2Epdf%26;parent=%2Fsites%2FWebsite%2FDelte%20dokumenter%2FTechnical%20Documents%2FElisa%26;p=true%26;ga=1 (Accessed 2\/21\/2025)"},{"key":"2037_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12873-021-00544-x","volume":"21","author":"S Santeri","year":"2021","unstructured":"Santeri S, Peter AA, Kristiina N et al (2021) SuPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department. BMC Emerg Med 21:149. https:\/\/doi.org\/10.1186\/s12873-021-00544-x","journal-title":"BMC Emerg Med"},{"key":"2037_CR23","doi-asserted-by":"publisher","unstructured":"Sacco S, Braschinsky M, Ducros A et al (2020) European headache federation consensus on the definition of resistant and refractory migraine. J Headache Pain 21. https:\/\/doi.org\/10.1186\/s10194-020-01130-5","DOI":"10.1186\/s10194-020-01130-5"},{"key":"2037_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12891-020-3154-3","volume":"21","author":"P Morris","year":"2020","unstructured":"Morris P, Ali K, Merritt M et al (2020) A systematic review of the role of inflammatory biomarkers in acute, subacute and chronic non-specific low back pain. BMC Musculoskelet Disord 21:142. https:\/\/doi.org\/10.1186\/s12891-020-3154-3","journal-title":"BMC Musculoskelet Disord"},{"key":"2037_CR25","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/ejp.1630","volume":"24","author":"SF Farrell","year":"2020","unstructured":"Farrell SF, De Zoete RMJ, Cabot PJ, Sterling M (2020) Systemic inflammatory markers in neck pain: A systematic review with meta-analysis. Eur J Pain 24:1666\u20131686. https:\/\/doi.org\/10.1002\/ejp.1630","journal-title":"Eur J Pain"},{"key":"2037_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s10194-023-01672-4","volume":"24","author":"HG Da\u011f\u0131d\u0131r","year":"2023","unstructured":"Da\u011f\u0131d\u0131r HG, Topa E, Vuralli D, Bolay H (2023) Medication overuse headache is associated with elevated lipopolysaccharide binding protein and pro-inflammatory molecules in the bloodstream. J Headache Pain 24:150. https:\/\/doi.org\/10.1186\/s10194-023-01672-4","journal-title":"J Headache Pain"},{"key":"2037_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Stat Soc Ser B (Methodological) 57:289\u2013300","journal-title":"J Royal Stat Soc Ser B (Methodological)"},{"key":"2037_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen JC, Gluud C, Wetterslev J, Winkel P (2017) When and how should multiple imputation be used for handling missing data in randomised clinical trials\u2013 a practical guide with flowcharts. BMC Med Res Methodol 17:162. https:\/\/doi.org\/10.1186\/s12874-017-0442-1","journal-title":"BMC Med Res Methodol"},{"key":"2037_CR29","unstructured":"R Core Team (2021) R: A Language and environment for statistical computing. R Foundation for Statistical Computing"},{"key":"2037_CR30","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"2037_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"2037_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP et al (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18:795\u2013804. https:\/\/doi.org\/10.1016\/S1474-4422(19)30185-1","journal-title":"Lancet Neurol"},{"key":"2037_CR33","doi-asserted-by":"publisher","unstructured":"Spekker E, Tanaka M, Szab\u00f3 \u00c1, V\u00e9csei L (2022) Neurogenic inflammation: the participant in migraine and recent advancements in translational research. https:\/\/doi.org\/10.3390\/biomedicines10010076. Biomedicines 10:","DOI":"10.3390\/biomedicines10010076"},{"key":"2037_CR34","doi-asserted-by":"publisher","first-page":"106072","DOI":"10.1016\/j.nbd.2023.106072","volume":"180","author":"L Biscetti","year":"2023","unstructured":"Biscetti L, Cresta E, Cupini LM et al (2023) The putative role of neuroinflammation in the complex pathophysiology of migraine: from bench to bedside. Neurobiol Dis 180:106072. https:\/\/doi.org\/10.1016\/j.nbd.2023.106072","journal-title":"Neurobiol Dis"},{"key":"2037_CR35","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.1231897","volume":"339","author":"H Karatas","year":"2013","unstructured":"Karatas H, Erdener SE, Gursoy-Ozdemir Y et al (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339:1092\u20131095. https:\/\/doi.org\/10.1126\/science.1231897","journal-title":"Science"},{"key":"2037_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1748-1716.1980.tb06557.x","volume":"109","author":"AJ Hansen","year":"1980","unstructured":"Hansen AJ, Quistorff B, Gjedde A (1980) Relationship between local changes in cortical blood flow and extracellular K+ during spreading depression*. Acta Physiol Scand 109:1\u20136. https:\/\/doi.org\/10.1111\/j.1748-1716.1980.tb06557.x","journal-title":"Acta Physiol Scand"},{"key":"2037_CR37","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1523\/JNEUROSCI.4498-15.2016","volume":"36","author":"S Wendt","year":"2016","unstructured":"Wendt S, Wogram E, Korvers L, Kettenmann H (2016) Experimental cortical spreading depression induces NMDA receptor dependent potassium currents in microglia. J Neurosci 36:6165\u20136174. https:\/\/doi.org\/10.1523\/JNEUROSCI.4498-15.2016","journal-title":"J Neurosci"},{"key":"2037_CR38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/00004647-200103000-00005","volume":"21","author":"S Jander","year":"2001","unstructured":"Jander S, Schroeter M, Peters O et al (2001) Cortical spreading depression induces Proinflammatory cytokine gene expression in the rat brain. J Cereb Blood Flow Metab 21:218\u2013225. https:\/\/doi.org\/10.1097\/00004647-200103000-00005","journal-title":"J Cereb Blood Flow Metab"},{"key":"2037_CR39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/01.WCB.0000126566.34753.30","volume":"24","author":"PE Kunkler","year":"2004","unstructured":"Kunkler PE, Hulse RE, Kraig RP (2004) Multiplexed cytokine protein expression profiles from spreading depression in hippocampal organotypic cultures. J Cereb Blood Flow Metab 24:829\u2013839. https:\/\/doi.org\/10.1097\/01.WCB.0000126566.34753.30","journal-title":"J Cereb Blood Flow Metab"},{"key":"2037_CR40","doi-asserted-by":"publisher","first-page":"051","DOI":"10.1385\/MN:32:1:051","volume":"32","author":"CS Thompson","year":"2005","unstructured":"Thompson CS, Hakim AM (2005) Cortical spreading depression modifies components of the inflammatory cascade. MN 32:051\u2013058. https:\/\/doi.org\/10.1385\/MN:32:1:051","journal-title":"MN"},{"key":"2037_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1460-9568.2006.04862.x","volume":"24","author":"A Urbach","year":"2006","unstructured":"Urbach A, Bruehl C, Witte OW (2006) Microarray-based long-term detection of genes differentially expressed Af cortical spreading depression. Eur J Neurosci 24:841\u2013856","journal-title":"Eur J Neurosci"},{"key":"2037_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.expneurol.2014.12.001","volume":"264","author":"AD Pusic","year":"2015","unstructured":"Pusic AD, Mitchell HM, Kunkler PE et al (2015) Spreading depression transiently disrupts Myelin via interferon-gamma signaling. Exp Neurol 264:43\u201354. https:\/\/doi.org\/10.1016\/j.expneurol.2014.12.001","journal-title":"Exp Neurol"},{"key":"2037_CR43","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/j.pain.0000000000001789","volume":"161","author":"AJ Schain","year":"2020","unstructured":"Schain AJ, Melo-Carrillo A, Ashina S et al (2020) Celecoxib reduces cortical spreading depression\u2013induced macrophage activation and dilatation of dural but not Pial arteries in rodents: implications for mechanism of action in terminating migraine attacks. Pain 161:1019\u20131026. https:\/\/doi.org\/10.1097\/j.pain.0000000000001789","journal-title":"Pain"},{"key":"2037_CR44","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/jnc.12267","volume":"126","author":"YY Grinberg","year":"2013","unstructured":"Grinberg YY, Dibbern ME, Levasseur VA, Kraig RP (2013) Insulin-like growth factor\u20101 abrogates microglial oxidative stress and TNF \u2010\u03b1 responses to spreading depression. J Neurochem 126:662\u2013672. https:\/\/doi.org\/10.1111\/jnc.12267","journal-title":"J Neurochem"},{"key":"2037_CR45","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1177\/03331024221118924","volume":"42","author":"J Thuraiaiyah","year":"2022","unstructured":"Thuraiaiyah J, Erritz\u00f8e-Jervild M, Al-Khazali HM et al (2022) The role of cytokines in migraine: A systematic review. Cephalalgia 42:1565\u20131588. https:\/\/doi.org\/10.1177\/03331024221118924","journal-title":"Cephalalgia"},{"key":"2037_CR46","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/glia.20892","volume":"57","author":"O Cunningham","year":"2009","unstructured":"Cunningham O, Campion S, Perry VH et al (2009) Microglia and the urokinase plasminogen activator receptor\/upa system in innate brain inflammation. Glia 57:1802\u20131814. https:\/\/doi.org\/10.1002\/glia.20892","journal-title":"Glia"},{"key":"2037_CR47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3988\/jcn.2021.17.2.164","volume":"17","author":"M Paolucci","year":"2021","unstructured":"Paolucci M, Altamura C, Vernieri F (2021) The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: A narrative review. J Clin Neurol 17:164. https:\/\/doi.org\/10.3988\/jcn.2021.17.2.164","journal-title":"J Clin Neurol"},{"key":"2037_CR48","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/0333102417698936","volume":"38","author":"GE Tietjen","year":"2018","unstructured":"Tietjen GE, Khubchandani J, Herial N et al (2018) Migraine and vascular disease biomarkers: A population-based case-control study. Cephalalgia: Int J Headache 38:511\u2013518. https:\/\/doi.org\/10.1177\/0333102417698936","journal-title":"Cephalalgia: Int J Headache"},{"key":"2037_CR49","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1096\/fj.02-0484fje","volume":"17","author":"MA Behzadian","year":"2003","unstructured":"Behzadian MA, Windsor LJ, Ghaly N et al (2003) VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J 17:752\u2013754. https:\/\/doi.org\/10.1096\/fj.02-0484fje","journal-title":"FASEB J"},{"key":"2037_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nm0202-136","volume":"8","author":"H Bolay","year":"2002","unstructured":"Bolay H, Reuter U, Dunn AK et al (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8:136\u2013142. https:\/\/doi.org\/10.1038\/nm0202-136","journal-title":"Nat Med"},{"key":"2037_CR51","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1523\/JNEUROSCI.0232-19.2019","volume":"39","author":"AJ Schain","year":"2019","unstructured":"Schain AJ, Melo-Carrillo A, Stratton J et al (2019) CSD-Induced arterial dilatation and plasma protein extravasation are unaffected by fremanezumab: implications for CGRP\u2019s role in migraine with aura. J Neurosci 39:6001\u20136011. https:\/\/doi.org\/10.1523\/JNEUROSCI.0232-19.2019","journal-title":"J Neurosci"},{"key":"2037_CR52","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1172\/JCI200421227","volume":"113","author":"Y Gursoy-Ozdemir","year":"2004","unstructured":"Gursoy-Ozdemir Y, Qiu J, Matsuoka N et al (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113:1447\u20131455. https:\/\/doi.org\/10.1172\/JCI200421227","journal-title":"J Clin Invest"},{"key":"2037_CR53","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/brain\/awx089","volume":"140","author":"A Hougaard","year":"2017","unstructured":"Hougaard A, Amin FM, Christensen CE et al (2017) Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura. Brain 140:1633\u20131642. https:\/\/doi.org\/10.1093\/brain\/awx089","journal-title":"Brain"},{"key":"2037_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/172460080101600402","volume":"16","author":"R Riisbro","year":"2001","unstructured":"Riisbro R, Christensen IJ, H\u00f8gdall C et al (2001) Soluble urokinase plasminogen activator receptor measurements: influence of sample handling. Int J Biol Markers 16:233\u2013239. https:\/\/doi.org\/10.1177\/172460080101600402","journal-title":"Int J Biol Markers"},{"key":"2037_CR55","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1007\/s00415-023-12103-4","volume":"271","author":"P Barbanti","year":"2024","unstructured":"Barbanti P, Aurilia C, Egeo G et al (2024) Ultra-late response (>\u200924 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. J Neurol 271:2434\u20132443. https:\/\/doi.org\/10.1007\/s00415-023-12103-4","journal-title":"J Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02037-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02037-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02037-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T06:02:22Z","timestamp":1745474542000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02037-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02037-9","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The REFORM study received approval from both the Danish Data Protection Agency and the ethics committee of the Capital Region of Denmark (H-20033264 and H-20047793). All participants were given appropriate time to consider participation and provided written informed consent before undergoing any study-related procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WKK and HMA have each received a speaker\u2019s honorarium from Pfizer and Lundbeck outside of the submitted work. RHC has received personal fees from Teva, the Lundbeck Foundation and research travel funding from Augustinus Fonden. TK and BNJ have no conflicts to report. OA is named inventor on patents covering suPAR owned by Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark and licensed to ViroGates A\/S. MA is a consultant, speaker, or scientific advisor for AbbVie, Amgen, Astra Zeneca, Eli Lilly, GlaxoSmithKline, Lundbeck, Novartis, Pfizer, and Teva; a primary investigator for ongoing AbbVie and Pfizer trials; and is the past president of the International Headache Society. MA is supported through the Lundbeck Foundation Professor Grant (R310-2018-3711) and serves as associate editor of the Journal of Headache and Pain and associate editor of Brain. HA reports personal fees from AbbVie, Lundbeck, Pfizer, and Teva outside of the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}